101
|
Chen F, Kuhberg M, Skowronek P, Schwarz J, Lichtenegger W, Sehouli J. P51 Nutritional status and clinical outcome of elderly women with primary or recurrent ovarian cancer: results of a prospective study. Crit Rev Oncol Hematol 2009. [DOI: 10.1016/s1040-8428(09)70089-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
102
|
Mahner S, Wölber L, zu Eulenburg C, Schwarz J, Milde-Langosch K, Müller V, Jänicke F. Longitudinale Veränderung und prognostische Bedeutung der Serum-Marker VEGF und TIMP-1 während der Ovarialkarzinom-Primärtherapie. Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1238987] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
103
|
McKeen S, Grell G, Peckham S, Wilczak J, Djalalova I, Hsie EY, Frost G, Peischl J, Schwarz J, Spackman R, Holloway J, de Gouw J, Warneke C, Gong W, Bouchet V, Gaudreault S, Racine J, McHenry J, McQueen J, Lee P, Tang Y, Carmichael GR, Mathur R. An evaluation of real-time air quality forecasts and their urban emissions over eastern Texas during the summer of 2006 Second Texas Air Quality Study field study. ACTA ACUST UNITED AC 2009. [DOI: 10.1029/2008jd011697] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
104
|
Skowronek P, Kuhberg M, Chen F, Schwarz J, Lichtenegger W, Sehouli J. Impact of malnutrition on surgical outcome of patients with ovarian cancer: Results of a prospective study. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e16564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e16564 Background: The purpose of this study was to examine an influence of poor nutritional status on surgical outcome in patients with ovarian cancer. Methods: Data from 152 consecutive patients with histologically confirmed ovarian cancer were prospectively analyzed. Overall 79 suffered from primary and 73 from recurrent disease. All patients received a systematic nutritional assessment prior to cytoreductive surgery and postoperative all complications were analyzed in detail. The Nutritional Risk Score (NRS-2002) was used to identify patients at high nutritional risk (NRS≥3). Intraoperatively, a standardized documentation script (IMO) was applied including tumor localization, surgical interventions, and postoperative residual tumor mass. Results: 29 patients (19%) were classified as malnourished, including 19 (24%) with primary and 10 (14%) with recurrent disease. These patients showed a significantly poorer performance status preoperatively compared to patients with NRS<3 (p < 0.05), which was assessed according to the American Society of Anesthesiologists (ASA). Also an intra-operatively documented tumor spread was significantly more extended in group with NRS≥3 than among patients with NRS<3 (p < 0.05). In malnourished patients complete resection rate was significantly decreased (31% vs. 69%, p < 0.001) and they required more often a colo- or ileostoma (17% vs. 6%, p = 0.041). Malnourished patients suffered more often from post-operative complications (62% vs. 37%, p < 0.05), especially infectious like pneumonia or sepsis. All postoperative mortality events (3 cases) occurred in the malnourished group. Conclusions: Malnourished ovarian cancer patients have significantly more often post-operative complications. They suffer from more extended tumor spread and were less frequently postoperatively tumor-free. Based on our results further prospective trials of preoperative nutritional therapy to improve surgical outcome are warranted. No significant financial relationships to disclose.
Collapse
|
105
|
Schwarz J. Comparative Epidemiology of Four Deep Mycoses - a Review/Vergleichende Epidemiologie von vier tiefen (Organ-) Mykosen - eine Übersicht. Mycoses 2009. [DOI: 10.1111/j.1439-0507.1986.tb03249.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
106
|
|
107
|
|
108
|
Hesse S, Barthel H, Strecker K, Oehlwein C, Sabri O, Schwarz J. Nuklearmedizinische Diagnostik beim Parkinson-Syndrom. AKTUELLE NEUROLOGIE 2008. [DOI: 10.1055/s-2008-1067504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
109
|
Mahner S, Baasch C, Schwarz J, Wölber L, Jänicke F, Milde-Langosch K. C-Fos Expression as Predictor of Progression and Survival in Epithelial Ovarian Carcinoma. Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-0028-1088673] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
110
|
Schwarz J, Darcel N, Rampin O, Andrey P, Burguet J, Fromentin G, Maurin Y, Tome D. Activation maps in the nucleus of the solitary tract (NTS) in response to internal stimuli. Appetite 2008. [DOI: 10.1016/j.appet.2008.04.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
111
|
Schwarz J, Darcel N, L’Heureux-Bouron D, Gougis S, Rampin O, Tome D, Fromentin G. Hepatic portal vein deafferentation has no effect on the satiating effect of a HP diet. Appetite 2008. [DOI: 10.1016/j.appet.2008.04.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
112
|
Schollmeier M, Becker S, Geissel M, Flippo KA, Blazević A, Gaillard SA, Gautier DC, Grüner F, Harres K, Kimmel M, Nürnberg F, Rambo P, Schramm U, Schreiber J, Schütrumpf J, Schwarz J, Tahir NA, Atherton B, Habs D, Hegelich BM, Roth M. Controlled transport and focusing of laser-accelerated protons with miniature magnetic devices. PHYSICAL REVIEW LETTERS 2008; 101:055004. [PMID: 18764401 DOI: 10.1103/physrevlett.101.055004] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2008] [Indexed: 05/26/2023]
Abstract
This Letter demonstrates the transporting and focusing of laser-accelerated 14 MeV protons by permanent magnet miniature quadrupole lenses providing field gradients of up to 500 T/m. The approach is highly reproducible and predictable, leading to a focal spot of (286 x 173) microm full width at half maximum 50 cm behind the source. It decouples the relativistic laser-proton acceleration from the beam transport, paving the way to optimize both separately. The collimation and the subsequent energy selection obtained are perfectly applicable for upcoming high-energy, high-repetition rate laser systems.
Collapse
|
113
|
Moßhammer D, Muche R, Mörike K, Meznaric S, Schwarz J, Lorenz G. Prävalenz der Statinverschreibung und ihre Assoziation mit Muskelbeschwerden bei hausärztlichen Patienten – eine Querschnittsuntersuchung. DAS GESUNDHEITSWESEN 2008. [DOI: 10.1055/s-0028-1086410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
114
|
Schwarz J, Kacírková P, Marková J, Mikulenková D, Marinov I, Ballingová I, Michalová K. [Urgent states in hematology: acute promyelocytic leukemia--principles of diagnosis]. VNITRNI LEKARSTVI 2008; 54:728-744. [PMID: 18780572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
A review of diagnosis of acute promyelocytic leukemia (APL) is presented. There are still many patients with progressive disease with leukocytosis at presentation. These are at greater risk of early death due to bleeding (often intracranial), or, less frequently, due to thrombotic complications. In Czechia, we have, in some instances, noted an unacceptably long time from the first symptoms to diagnosis and to administration of the highly specific differentiation therapy with tretinoin (ATRA) along with anthracycline chemotherapy. This combination is highly efficient--cures are seen in some 70% of patients. Therefore, we present a diagnostic minimum for each and every internist, and even better for every general practician, to get acquainted with. All cases of pancytopenia and consumption coagulopathy should be suspected of APL and referred to a specialized hematologist without any delay. In the following more detailed review of diagnostic measures, much attention is given to APL morphology, which is the first clue leading to diagnosis. The finding of the typical hypergranular FAB M3 morphology and of cells with bundles of Auer rods ("faggot cells"), along with the HLA-DR, CD33+ immunophenotype, is highly (but not absolutely) specific for APL. In cases of the micro-/hypo-granular variant FAB M3v Form, and whenever APL cannot be ruled out with certainty, a test to prove the presence of the PML/RARalpha fusion gene is indicated, using either RT-PCR or, eventually, immunological demonstration of the specific distribution of the PML protein in the cell nucleus. Given that morphology of APL cases, as defined according to WHO criteria (95% of which carry the PML/RARalpha fusion gene), admits extremely divergent morphological pictures ofthe variant forms, we recommend these investigations to be performed in every case of de novo acute myeloid leukemia. A review of the less frequent morphological, as well as genetic variants is given, and the principles of immunophenotypic, cytogenetic and molecular diagnostics are also reviewed.
Collapse
|
115
|
Korístek Z, Schwarz J, Zák P. [Brief case reports illustrate various initial courses in acute promyelocytic leukemia]. VNITRNI LEKARSTVI 2008; 54:771-773. [PMID: 18780576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Authors present cases which illustrate a various initial symptoms and courses of patients between the first symptoms and the diagnosis of acute promyelocytic leukemia. Symptoms indicated possible serious hematological diseases are well-known: unusual bleeding, recurrent infections or infections not responded to antibiotics, fatigue, anemia symptoms. The disease progression was sometimes very rapid, however, in certain patients the symptoms were disappreciated or even minimized and the approaches were not adequate to risks resulted from newly diagnosed acute promyelocytic leukemia.
Collapse
|
116
|
Schwarz J. [From chloroma to acute promyelocytic leukemia--a historical perspective]. VNITRNI LEKARSTVI 2008; 54:686-700. [PMID: 18780570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The progressing knowledge on chloroma and chloroleukemia is reviewed. However, it is uneasy to identify with certainty the cases of acute promyelocytic leukemia (APL) among the historical descriptions ofchloroma since 1823. In part, this is due to confusion produced by the historical cytological nomenclature--in practice, the leukemic promyelocytes were regarded, quite inaccurately, as a subtype of paramyeloblasts until early 1960's. The term promyelocytic leukemia first appeared in Naegeli's text-book in 1931. However, no clinical associations of the morphological description were then given. As a clinico-pathological entity, APLwas defined by Hillestad in Norway in 1957 and on a more detailed level, by Bernard et al in France in 1959. However, the descriptions of chloroma by Butterfield in 1909 and of leukemia with panmyelophthisis and defibrination by Risak in 1935 in the German-written literature and the case of chloroma described by Libánský in Czech in 1939 were cases of APL with high probability. Further on, experimental studies leading to the postulation of possible differentiation-inducing therapy of leukemia are reviewed--the importance of introducing of clonal culture of hematopoietic cells in the 1960's and the proof of the possibility of bypassing the maturation block in the works of Sachs's group in Rehovot, Israel, is stressed, as well as the later experiments with differentiation inducers in the cell line models in the 1970's and 1980's. The first trials with retinoids in therapy of APL are mentioned, along with the interesting background of the French-Chinese collaboration (under the auspices of professors Degos and Wang) in the introduction of retinoids into practice in the second half of the 1980's. It is discussed how the success of the clinical trials led to enormous progression in the field of molecular genetics of APL, which, in turn, led to development of a new generation of remedies, i.e. to the renaissance of arsenic in the treatment of APL in the 1990's, among others thanks to the current Chinese minister of health, Chen Zhu.
Collapse
MESH Headings
- History, 19th Century
- History, 20th Century
- History, 21st Century
- Humans
- Leukemia, Promyelocytic, Acute/diagnosis
- Leukemia, Promyelocytic, Acute/history
- Leukemia, Promyelocytic, Acute/therapy
- Sarcoma, Myeloid/diagnosis
- Sarcoma, Myeloid/history
- Sarcoma, Myeloid/therapy
Collapse
|
117
|
Penka M, Schwarz J, Pavlík T, Pytiĺk R, Doubek M, Dulícek P, Kissová J, Hlusi A, Schutzová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Dusek L. [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]. VNITRNI LEKARSTVI 2008; 54:775-782. [PMID: 18780577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The registry of patients treated with Thromboreductine (anagrelid) in the contributing centres in the Czech Republic has been updated with data on the patients receiving this medication since 2004. The original purpose of the registry was to record responses to Thromboreductine therapy and adverse drug reactions in patients with essential thrombocytopenia. However, data on additional Ph negative myeloproliferations, as well as data on cytoreductive therapies other than exclusively that using Thromboreductine has also been recorded in the course of its compilation, including data on combined regimes. At present, the database contains data on 421 patients, and valid conclusions can be drawn if the level of data filling is enhanced. Evaluation has been currently focused on the analysis of the risk of development of clinical symptoms of thrombosis and on the standards of treatment from the viewpoint of the achieved treatment response. Analyses of data from the registry corroborate the special importance of the proof of JAK2 mutation, and of the test for factor V Leiden mutation, and of protein of S for the assessment of the risk of thromboembolic complications. The output of the analysis confirms that anagrelid is a very efficient thromboreductive agent the administration of which is associated with a low incidence of non-serious adverse effects (10.9%). However, in spite of a fast response to therapy, the therapeutic goal consisting in the reduction of the platelet count below 400 (or below 600) x 10(9)/l, i.e. the complete (or partial) treatment response, is relatively slow to achieve. This is likely to be due to lack of radical corrections in the dosage of the drug for different reasons.
Collapse
|
118
|
Schwarz J, Korístek Z, Starý J, Zák P, Kozák T, Marková J, Michalová K, Dvoráková D, Mayer J, Cetkovský P. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors]. VNITRNI LEKARSTVI 2008; 54:757-770. [PMID: 18780575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
We have retrospectively evaluated a cohort of 144 patients (including 17 pediatric ones) with de novo acute promyelocytic leukemia registered in databases of institutions cooperating within the CELL group (The Czech Leukemia Study Group for Life). The patients were diagnosed according to WHO criteria from 1989 until 2006. The aim was to check how well fared the patients, the majority of whom was not included into clinical trials, in real life. Of 140 evaluable patients, 97 (69.3%) attained complete remission (CR). The projected overall survival (OS) 4 years after diagnosis was 58.9%, and 55.3% at 6 years. In 8 patients (6.0%), no antileukemic therapy at all was given (either they died shortly after admission to the ward or therapy was not feasible due to their clinical status). Of 125 patients with documented commencement of some kind of therapy, 96 (76.8%) achieved CR. Of 102 patients with induction treatment with a combination of anthracycline and tretinoin (ATRA), 84 individuals (82.4%) attained CR (typically, this cohort might have been subjected to clinical trials). This result was better than that of patients treated by chemotherapy only (n = 15; CR 46.7%; P = 0.003) or by ATRA monotherapy (n = 13; CR 62.5%; P = 0.17). Another parameter with a significant impact on attaining CR was the leukocyte (WBC) count at diagnosis: its median values in patients achieving and not achieving CR were 2.1 and 24.0 x 10(9)/l, respectively (P < 0.0001). The WBC counts affected OS as well (P = 0.0001). However, when only patients after attaining CR were evaluated, the initial WBC counts no longer affected OS (P = 0.18). Achieving CR was also influenced by the performance status (PS) 0-1 (P = 0.005), which was in turn closely correlated to WBC counts (P = 0.0006). Additional factors (most likely connected with leukocytosis) influenced attaining CR with borderline statistical significance: e.g. FAB M3v morphology, LDH serum level, fibrinogen level, presence of internal tandem duplication (ITD) of the FLT3 gene (which was strongly associated with leukocytosis and also with the short PML/RARalpha transcript resulting from the bcr3 break in the PML gene). It may be speculated that FLT3-ITD is just one of the possible factors that lead to leukocytosis. The platelet counts at diagnosis had no impact on entering CR. Thus, we have not validated the current PETHEMA risk stratification in distinguishing intertermediate and low risk patients. Our study points to a significant difference of the results obtained in real life and of the results that could be achieved in patients who were fit to enter clinical trials. Among the prognostic factors, the most important one was the WBC count, the PS (which is highly affected by the WBC count), and feasibility of administration of the most potent induction therapy with anthracyclines and ATRA.
Collapse
|
119
|
Schwarz J, Rambo P, Geissel M, Edens A, Smith I, Brambrink E, Kimmel M, Atherton B. Activation of the Z-petawatt laser at Sandia National Laboratories. ACTA ACUST UNITED AC 2008. [DOI: 10.1088/1742-6596/112/3/032020] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
120
|
Schwarz J, Schwegler J, Augustin M, Ihnen M, Mahner S, Wölber L. Untersuchungen zur Effektivität von Clobetasol 0,05 % in der Therapie des Lichen sclerosus der Vulva. Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-2008-1038615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
121
|
Förstl H, Gratz S, Hahn U, Schwarz J, Jarnig M. [Dementia with Lewy bodies and reduced dopamine transporter binding indicates significant acetylcholine deficiency]. Dtsch Med Wochenschr 2008; 133 Suppl 1:S11-4. [PMID: 18437636 DOI: 10.1055/s-2008-1075680] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Dementia with Lewy bodies (DLB) is the second most common form of neurodegenerative dementia. It is usually caused by a mixture of symptoms of Parkinson's and Alzheimer's disease leading to a significant impairment of nigro-striatal dopaminergic and baso-cortical cholinergic neurotransmission with typical clinical symptoms of a fluctuating course, hallucinations, parkinsonism, REM-sleep disorder and neuroleptic hypersensitivity. If the clinical presentation of DLB is uncharacteristic, the demonstration of reduced presynaptic striatal dopamine transporter (DaT) sites supports a suspicion of DLB and may lead to important therapeutic consequences. In these circumstances this evidence for compromised dopaminergic neurotransmission also indicates a significant cholinergic deficit: both require diligent therapeutic attention.
Collapse
|
122
|
Schwarz J, Gratz S, Hahn U, Förstl H, Jarnig M. [The status of imaging methods for the treatment of patients with Parkinson's syndrome]. Dtsch Med Wochenschr 2008; 133 Suppl 1:S8-10. [PMID: 18437640 DOI: 10.1055/s-2008-1075679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
The accuracy of the diagnosis of Parkinson's disease early in the course of the disease remains a clinical challenge. Imaging of dopamine transporters with DatSCAN and SPEC tomography contributes to identifying patients without nigral degeneration and thus helps preventing unnecessary and potentially harmful treatments. The cost of these imaging procedures needs to be set against the cost of unnecessary medication.
Collapse
|
123
|
Mahner S, Baasch C, Woelber L, Beck K, Schwarz J, Jaenicke F, Milde-Langosch K. Prognostic significance of c-Fos expression in epithelial ovarian carcinoma. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.16540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
124
|
Hahn U, Schwarz J, Gratz S, Kaiser J, Jarnig M, Förstl H. Morphologische Magnetresonanz-Tomographie: Ihre Wertigkeit bei der Diagnose neurodegenerativer Erkrankungen. Dtsch Med Wochenschr 2008; 133 Suppl 1:S15-8. [DOI: 10.1055/s-2008-1075681] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
125
|
Gratz S, Hahn U, Kaiser J, Jarnig M, Schwarz J, Förstl H. Nuklearmedizinische Bildgebung bei zerebralen Erkrankungen. Dtsch Med Wochenschr 2008; 133 Suppl 1:S5-7. [DOI: 10.1055/s-2008-1075678] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
126
|
Müller F, Schwarz J, Stark M, Ulrich U. Allgemeine Gynäkologie. Endoskopische Chirurgie durch natürliche Körperöffnungen (NOTES - Natural Orifice Transluminal Endoscopic Surgery). Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-2008-1038653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
127
|
Schwarz J. Membranströme und Aktionspotentiale markhaltiger Nervenfasern und ihre Beeinflussung durch Diphenylhydantoin und Tokainid. KLIN NEUROPHYSIOL 2008. [DOI: 10.1055/s-2008-1060867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
128
|
|
129
|
Berkova A, Pavlistova L, Babicka L, Houskova L, Tajtlova J, Balazi P, Cmunt E, Schwarz J, Karban J, Trneny M, Brezinova J, Zemanova Z, Michalova K. Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia. Neoplasma 2008; 55:400-408. [PMID: 18665750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Interphase fluorescence in situ hybridization was used to detect common deletions in B-CLL patients as well as trisomy 12 and aberrations of IgH gene complex at 14q32.33 where we evaluated not only translocation-like signal pattern but also deletions. 120 (82%) patients showed genetic changes - del(13)(q14) 95 (62%), deletion of ATM gene 22 (15%), deletion of p53 gene 25 (17%) and trisomy 12 was proved in 18 (12%) cases. IgH rearrangements were detected in 45 (31%), split of the signals in 11 (8%), deletion of 3' segment flanking IgH gene in 5 (3%) and deletions of variable segment in 29 (20%) patients. Although deletions of 3' segment flanking IgH gene complex are supposed to have an adverse prognostic impact and the genetic background of variable segment deletions is believed to be most probably physiological, we assumed a detailed mapping of the 14q32.33 region will be needed to unravel these mysteries.
Collapse
MESH Headings
- Aged
- Aged, 80 and over
- Chromosome Aberrations
- Chromosomes, Human, Pair 12
- Chromosomes, Human, Pair 13
- Chromosomes, Human, Pair 14
- Cytogenetic Analysis
- Female
- Humans
- Immunoglobulin Heavy Chains/genetics
- In Situ Hybridization, Fluorescence
- Leukemia, Lymphocytic, Chronic, B-Cell/genetics
- Male
- Middle Aged
- Molecular Diagnostic Techniques
- Mutation
- Retrospective Studies
- Survival Analysis
- Trisomy
Collapse
|
130
|
Hermann W, Günther P, Kühn H, Schneider J, Eichelkraut S, Villmann T, Strecker K, Schwarz J, Wagner A. FAEP und Morphometrie des Mesenzephalons bei Morbus Wilson. AKTUELLE NEUROLOGIE 2007. [DOI: 10.1055/s-2007-986233] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
131
|
Strecker K, Hesse S, Wegner F, Sabri O, Schwarz J, Schneider JP. Eye of the Tiger sign in multiple system atrophy. Eur J Neurol 2007; 14:e1-2. [PMID: 17956429 DOI: 10.1111/j.1468-1331.2007.01925.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
132
|
Ihnen M, Mahner S, Jänicke F, Schwarz J. Current treatment options in uterine endometrial stromal sarcoma: report of a case and review of the literature. Int J Gynecol Cancer 2007; 17:957-63. [PMID: 17359294 DOI: 10.1111/j.1525-1438.2007.00889.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Uterine sarcomas are a rare form of uterine cancer. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. Endometrial stromal sarcoma (ESS) accounts for 0.2% of all gynecological malignancies. Forms of possible treatment include surgery, radiotherapy, chemotherapy, and endocrine treatment. Randomized trials analyzing these treatment options are limited due to the rarity of this disease; therefore, a standard therapy could not be established thus far. To present an overview of the current treatment options of ESS, a search of Medline, Embase, and the Cochrane Library was performed and the results concluded. We report the case of a 32-year-old woman who presented with FIGO stage II ESS. Initial treatment with tamoxifen and local perfusion with cisplatin resulted in disease progression and were discontinued. A novel, therapeutic approach using two cycles of combination chemotherapy with doxorubicin and ifosfamide followed by surgery was applied. Five years after surgery, the patient is still in complete remission. Thus, we conclude that although there is no data from randomized trials available, chemotherapy in advanced or metastatic ESS can provide an opportunity for surgical treatment and can lead to long-term remission.
Collapse
|
133
|
Schwarz J, Storch A. Progressive supranukleäre Paralyse (PSP). AKTUELLE NEUROLOGIE 2007. [DOI: 10.1055/s-2007-980073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
134
|
Schwarz J, Arnold G, Csoti I, Fogel W, Oechsner M, Urban P, Walter U, Storch A. Progressive supranukleäre Paralyse (PSP). AKTUELLE NEUROLOGIE 2007. [DOI: 10.1055/s-2007-970931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
135
|
Silberer H, Wölber L, Fuchs L, Schwarz J. Prätherapeutische Bestimmung des Tumorstadiums bei Patientinnen mit Zervixkarzinom - Vergleich von klinischer Untersuchung, NMR und CT. Geburtshilfe Frauenheilkd 2007. [DOI: 10.1055/s-2007-965545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
136
|
Wölber L, Silberer H, Barthell L, Schwarz J, Gieseking F, Jänicke F. HPV-Impfung in Deutschland – Regionale Ergebnisse der weltweiten Impfstudien. Geburtshilfe Frauenheilkd 2007. [DOI: 10.1055/s-2007-988683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
137
|
Strecker K, Schneider JP, Sabri O, Wegner F, Then Bergh F, Schwarz J, Hesse S. Responsiveness to a dopamine agent in Holmes tremor--case report. Eur J Neurol 2007; 14:e9-e10. [PMID: 17388980 DOI: 10.1111/j.1468-1331.2006.01665.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
138
|
Penka M, Schwarz J, Pavlík T, Pytlík R, Doubek M, Dulícek P, Pospísilová D, Kissová J, Hlusí A, Schützová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Lhotanová T, Bubeník B, Zapletal O, Vránová M, Micaníková M, Dusek L. [Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]. VNITRNI LEKARSTVI 2007; 53:653-61. [PMID: 17702125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Since 2005, registers of patients treated with Thromboreductin (anagrelid) kept by some centres in the Czech Republic have been supplied with data concerning patients whose treatment with this preparation started in 2004. The purpose of the register is to record responses to therapy by Thromboreductin and adverse events in patients with essential thrombocytemia and other myeloproliferations, and to subsequently analyse the data. Another objective is to detect predisposition to clinical symptomatology and disease complications. Apart from thrombocyte count, additional risk factors are monitored. The database currently contains data for 336 patients. Initial analyses of data from the register point to the fact that anagrelid is a highly effective thromboreductive agent the administration of which is associated with relatively low incidence of adverse events (11.8 %) of mild and usually transitory nature. The therapeutic objective is attained at a relatively slow rate (according to overall stratification under 400 or under 600 x 10(9)/l thrombocytes), which is probably due to insufficient dose adjustment.
Collapse
|
139
|
Sambrook PN, Cameron ID, Chen JS, Cumming RG, Lord SR, March LM, Schwarz J, Seibel MJ, Simpson JM. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int 2007; 18:603-10. [PMID: 17216131 DOI: 10.1007/s00198-006-0290-z] [Citation(s) in RCA: 90] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2006] [Accepted: 10/30/2006] [Indexed: 10/23/2022]
Abstract
INTRODUCTION When subjects are selected on the basis of fall risk alone, therapies for osteoporosis have not been effective. In a prospective study of elderly subjects at high risk of falls, we investigated the influence of bone strength and fall risk on fracture. METHODS At baseline we assessed calcaneal bone ultrasound attenuation (BUA) as well as quantitative measures of fall risk in 2005 subjects in residential care. Incident falls and fractures were recorded (median follow-up 705 days). RESULTS A total of 6646 fall events and 375 low trauma fracture events occurred. The fall rate was 214 per 100 person years and the fracture rate 12.1 per 100 person years. 82% of the fractures could be attributed to falls. Although fracture rates increased with decreasing BUA (incidence rate ratio 1.94 for lowest vs. highest BUA tertile, p<0.002), incident falls also affected fracture incidence. Subjects who fell frequently (>3.15 falls/per person year) were 3.35 times more likely to suffer a fracture than those who did not fall. Some fall risk factors such as balance were associated with the lowest fracture risk lowest in the worst performing group. Multivariate analysis revealed higher fall rate, history of previous fracture, lower BUA, lower body weight, cognitive impairment and better balance as significant independent risk factors for fracture. CONCLUSIONS In the frail elderly, both skeletal fragility and fall risk including the frequency of exposure to falls are important determinants of fracture risk.
Collapse
|
140
|
Schwarz J, Simsa J, Pazdírek F. [Our experience with peroperative choledochoscopy]. ROZHLEDY V CHIRURGII : MESICNIK CESKOSLOVENSKE CHIRURGICKE SPOLECNOSTI 2007; 86:180-3. [PMID: 17626459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
INTRODUCTION Choledocholithiasis is nowadays managed endoscopicaly in the majority of patients. Open surgery with CBD exploration remains important, when endoscopy failed. The completeness of stones' extraction may be confirmed with choledochoscopy. METHOD The retrospective analysis of patients operated on choledocholithiasis within the period of seven years was performed. Two groups of patients were studied. First group was managed by choledocholithotomy followed by choledochoscopy. Second group underwent exploration of the common bile duct without choledochoscopy. Frequency of the residual stones in both groups was studied. Statistical evaluation was done using alpha2 test. The value of p < 0.05 was settled as statistically significant. RESULTS In the study period of seven years 46 patients were operated on CBD stones. Choledocholithotomy followed by intra-operative choledochoscopy was performed in 21 patients. No remnant stones were recorded in this group. Exploration of the CBD with stone extraction without choledochoscopy was done in 25 patients. In this group residual stones occurred in 3 patients. The result was not statistically significant, p = 0.10. CONCLUSIONS According to our experience and literature, intra-operative choledochoscopy can reduce frequency of the residual CBD stones. Peroperative choledochoscopy can thus be recommended as an accessory procedure to CBD exploration to prevent stones oversight.
Collapse
|
141
|
Trnková Z, Bedrlíková R, Marková J, Michalová K, Stöckbauer P, Schwarz J. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia. Neoplasma 2007; 54:383-90. [PMID: 17688368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Resistance to chemotherapy is one of the major obstacles to effective treatment in acute myeloid leukemia (AML). The most extensively studied protein involved in multidrug resistance (MDR) is the transmembrane glycoprotein P (P-gp), the product of the multidrug resistance gene 1 (MDR1). MDR1/P-gp overexpression is frequently observed in hematological malignancies, especially in acute leukemia, and has been reported to correlate with poor prognosis in acute myeloid leukemia (AML). The aim of this study was to evaluate the level of MDR1 gene expression in bone marrow and/or peripheral blood samples in 92 AML patients in relation to their prognosis. The analyzed group was stratified according to presence or absence of prognostically favorable aberrations (PFAs), such as t(15;17) with PML/RARalpha fusion gene, t(8;21) with AML1/ETO fusion gene or inv(16)/ t(16;16) with CBFbeta/MYH11 fusion gene. These prognostically favorable aberrations were detected by RT-PCR and/or standard cytogenetic techniques. MDR1 expression was detected by semiquantitative comparative RT-PCR using software-based evaluation. The levels of MDR1 expression in the bone marrow predicted induction of complete remission in the whole group of analyzed patients (P = 0.032). They were significantly lower in PFA negative patients who achieved complete remission compared to those who failed to achieve complete remission (P = 0.008). In PFA negative patients, MDR1 expression was higher when compared to PFA positive patients (P = 0.055). No such difference was found when analyzing peripheral blood samples. Our experiments showed no impact of MDR1 expression in bone marrow or peripheral blood cells on overall survival (P = 1.000 and P = 0.903 respectively). In summary, the present study shows the prognostic impact of MDR1 expression on induction of complete remission in AML patients. We confirmed that MDR1 overexpression is an unfavorable prognostic factor in AML, which may help to stratify the risk rate of PFA negative patients. In future studies, quantitative detection of MDR1 expression might be a valuable tool to predict prognosis in this patient subset.
Collapse
|
142
|
Hermann A, Maisel M, Wegner F, Milosevic J, Gerlach M, Schwarz J, Storch A. Electrophysiological properties of neural stem cell-derived midbrain neurons reveal functional dopaminergic differentiation as prerequisite for therapeutic approaches. AKTUELLE NEUROLOGIE 2007. [DOI: 10.1055/s-2007-987582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
143
|
Grosset D, Antonini A, Canesi M, Pezzoli G, Lees A, Shaw K, Cubo E, Martinez-Martin P, Rascol O, Negres-Pages L, Senard A, Schwarz J, Strecker K, Reichmann H, Storch A, Loehle M, Stocchi F. 2.262 Adherence to antiparkinson medication in a multi-centre European study. Parkinsonism Relat Disord 2007. [DOI: 10.1016/s1353-8020(08)70674-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
144
|
Schwarz J, Martin AR, Rutkowski BJ, Davis RC. Die Adsorption von Natrium‐Dodecylbenzolsulfonat durch Baumwolle. ACTA ACUST UNITED AC 2006. [DOI: 10.1002/lipi.19620640112] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
145
|
Mechsner S, Loddenkemper C, Beutler C, Thode J, Bartley J, Schwarz J, Ebert AD. Die Rolle des Oxytocin Rezeptors (OTR) und Vasopressin Rezeptors (VPR) in der Pathogenese der Adenomyosis uteri (AM)-assoziierten Dysmenorrhoe. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
146
|
Schwarz J, mechsner S, Bartley J, Thode J, Ebert AD. Interaktionen zwischen Endometriose- und Nervenzellen. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
147
|
Schwarz J, Mahner S, Albrecht C, Ihnen M, Hemminger G, Jänicke F. Prospektive Studie zum Vergleich von FDG-PET mit der konventionellen bildgebenden Diagnostik zum Nachweis residualen Tumorgewebes nach neoadjuvanter Chemotherapie vor einer Operation bei Patientinnen mit lokal fortgeschrittenem Mammakarzinom. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
148
|
Ihnen M, Mahner S, Schwarz J. Behandlungsstrategien von Condylomata acuminata in der Schwangerschaft: Fallbericht und Literaturstudie. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
149
|
Ruckhäberle E, Prefot P, Schäfer J, Schwarz J, Rody A, Joubert R, Kaufmann M. Entdeckung neuer Biomarker- Kandidaten beim Mammakarzinom mittels 2D/ MS Proteomics. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
150
|
Thode J, Mechsner S, Schwarz J, Bartley J, Beutler C, Ebert AD. Untersuchungen zur endokrinen Regulation der epidermal growth factor receptor (EGFR) Familie im Endometriose in vitro-Modell. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-952714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|